Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence
Xiuping Zhang, Xiangjun Chen, Bozhao Li, Shuai Xu, Zhouliang Wu, Minggen Hu, Zhi-Ming Zhao, Guodong Zhao, Changrong Wang, Wei Hong, Suping Li, Lu Li, Chungang Wang, Guangjun Nie, Rong Liu
Topics & Concepts
Hepatocellular carcinomaSorafenibDoxorubicinMedicineDrug deliveryDrugCancerChemotherapyCancer researchOncologyPharmacologyInternal medicineMaterials scienceNanotechnologyNanoplatforms for cancer theranosticsNanoparticle-Based Drug DeliveryHepatocellular Carcinoma Treatment and Prognosis